Back to index
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
Life Science Leader
Data Management and Information Technology—Do the Benefits Outweigh the Risks?
Life Science Leader
Advancing Sponsor/CRO Collaborations to Improve Preclinical Throughput
Life Science Leader
Not A Popularity Contest
PharmPro
Outsourcing Clinical Research: Established vs. Emerging Markets
April 2012
March 2012
February 2012
January 2012
December 2011
Pharma iQ
Overcoming Barriers to Forming Successful Relationships with CMOs in Emerging Markets
PharmPro
Who should be doing your Pharmaceutical Analytical Testing – a CRO or CMO?
Pharmaceutical Manufacturing
Rating Pharma Contract Manufacturers: Does Perception Equal Reality?
BioSpace
Nice Insight Announces Publication of Its Q4 CRO/CMO Quarterly Intelligence Report
November 2011
October 2011
Life Science Leader
Will A Focus On Innovation Pay Off For Custom Synthesis Providers?
FiercePharma Manufacturing
Top 10 Standout CMOs
BioPharm International
Contract Services Spending: Who's Spending What, and Where?
Pharmaceutical Outsouring
How Relevant are 483s in Terms of Compliance Perception?
SFGate, PRWeb
Therapure Biopharma Inc. wins The CMO Leadership Award
Life Science Leader
Social Media Leads To Editorial – And More
PharmPro
Sterile Manufacturing Oppportunities
Life Science Leader — CMO Leadership Awards supplement issue
It’s About the Customer
PharmaChem
Where do strategic business opportunities lie for mid-tier CROs?
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
NI Company News
NI Published Articles
NI Calendar of Events
NI Media Partners
Contact Us
September 16-18 Long Branch, NJ
 |
|
|
The Atlanta Post
July 2011
Written By
The Atlanta Post      
|
When Victor Coker realized that there was a gap in market analysis he stepped in with Nice Insight. The tool connects customers and vendors by providing businesses unfiltered feedback on their products. With an MBA from MIT this son of Sierra Leone has developed a system that is being used by on by the pharmaceutical and biotech companies in the U.S., Africa and around the world. |
|
|
 |
|
